Profil
David McElligott is the founder of Ranar Therapeutics, Inc. He is currently the Chief Scientific Officer at Accelerator Services Corp since 2012.
Previously, he held the position of Senior Director-Drug Discovery at ICOS Corp.
from 1997 to 2011.
He also worked as a Principal at The Salk Institute for Biological Studies and as Vice President-Research & Development at Groove Biopharma Corp.
Additionally, he served as a Professor at The Scripps Research Institute.
From 2017 to 2021, he was the Chief Scientific Officer at Petra Pharma Corp.
He was also the President of Borealis Biotechnology LLC from 2007 to 2008.
Dr. McElligott completed his undergraduate and doctorate degrees at the University of Iowa.
Aktive Positionen von David McElligott
| Unternehmen | Position | Beginn |
|---|---|---|
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Corporate Officer/Principal | 01.03.2012 |
Ranar Therapeutics, Inc.
Ranar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development on therapies | Gründer | 01.10.2021 |
Ehemalige bekannte Positionen von David McElligott
| Unternehmen | Position | Ende |
|---|---|---|
Petra Pharma Corp.
Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer diseases | Corporate Officer/Principal | 30.10.2021 |
Borealis Biotechnology LLC | Präsident | 30.08.2008 |
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Corporate Officer/Principal | - |
Ausbildung von David McElligott
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Health Technology |
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Groove Biopharma Corp.
Groove Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Focuses on the generation of novel microRNA therapeutics | Commercial Services |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Finance |
Petra Pharma Corp.
Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer diseases | Health Technology |
Borealis Biotechnology LLC | |
Ranar Therapeutics, Inc.
Ranar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development on therapies | Commercial Services |
















